Can GDF-15 Predict Bleeding Risk in VTE? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Timothy Hoberstorfer et al., adding:
“Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Growth differentiation factor-15 has been proposed as a marker of bleeding risk, but it did not deliver here.
In patients anticoagulated for acute venous thromboembolism, GDF-15 levels showed no association with clinically relevant bleeding and added nothing to existing bleeding prediction.
The result argues against using this biomarker to guide anticoagulation decisions in VTE.”
Title: Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Authors: Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Cornelia Englisch, Philip Kienzl, Benedikt Weber, Monika Fritzer-Szekeres, Ingrid Pabinger, Cihan Ay
Other articles about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Aug 1, 2026, 11:07Yashaswi Dhiman: Advancing Hemovigilance Through Award-Winning Science
-
Aug 1, 2026, 08:24Kayla Garrett: Transforming Expectations in Haemophilia A Care
-
Aug 1, 2026, 07:51Toyosi Onwuemene: Are We Measuring the Outcomes That Matter Most to Patients With TTP?
-
Aug 1, 2026, 07:51Christopher Kirkham: Could Platelet Activation Become a Liability for Your Antibody Programme?
-
Aug 1, 2026, 07:38Danny Hsu: Recognizing Excellence in Scientific Leadership at ISTH 2026
-
Aug 1, 2026, 07:24Ulrich Sachs: A New Strategy to Prevent Platelet Transfusion Refractoriness
-
Aug 1, 2026, 07:12Gijs Aertssen: New Evidence on Joint Prosthesis Survival in Inherited Bleeding Disorders
-
Aug 1, 2026, 06:58Nora Abazi Emini: New Insights into Factor XIII in Atypical Haemolytic Uraemic Syndrome
-
Aug 1, 2026, 06:30Understanding Natural Anticoagulant Deficiencies – JTH